Ticker League

ResMed (RMD) Free Cash Flow Bridge

Pinpoint what moved ResMed's free cash flow from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

FCF YoY

+12.14%

OCF YoY

+14.34%

Capex YoY

+53.22%

FCF Conversion Δ

-1.8 pp

Free cash flow bridge for ResMed (RMD) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: $189.88M

FCF bridge breakdown for ResMed (RMD) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow$1.56B
  • Operating Cash Flow$237.03M
  • Capital Expenditure−$47.15M
  • Free Cash Flow$1.75B
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology